The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment
出版年份 2020 全文链接
标题
The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume -, Issue -, Pages 1-15
出版商
Informa UK Limited
发表日期
2020-04-30
DOI
10.1080/13543784.2020.1762566
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models
- (2019) Giovanni Gravina et al. Cancers
- Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7
- (2019) Wu Di et al. Cell Death & Disease
- Effects of EphB4 receptor expression on colorectal cancer cells, tumor growth, vascularization and composition
- (2018) Elif Kadife et al. ACTA ONCOLOGICA
- Tyrosine kinase activity of EphA2 promotes its S897 phosphorylation and glioblastoma cell proliferation
- (2018) Yuho Hamaoka et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Long noncoding RNA BC005927 upregulates EPHB4 and promotes gastric cancer metastasis under hypoxia
- (2018) Xiangqiang Liu et al. CANCER SCIENCE
- EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition
- (2018) Song Hee Kim et al. CELLULAR SIGNALLING
- NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family
- (2018) Alix Tröster et al. ChemMedChem
- Design and synthesis of small molecule agonists of EphA2 receptor
- (2018) Aaron Petty et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- EphA3 Downregulation by Hypermethylation Associated with Lymph Node Metastasis and TNM Stage in Colorectal Cancer
- (2018) Yong Wang et al. DIGESTIVE DISEASES AND SCIENCES
- EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma
- (2018) Lijun Liu et al. MEDICAL SCIENCE MONITOR
- Notch signaling promotes serrated neoplasia pathway in colorectal cancer through epigenetic modification of EPHB2 and EPHB4
- (2018) Haifeng Lian et al. Cancer Management and Research
- EZH2-mediated epigenetic suppression of EphB3 inhibits gastric cancer proliferation and metastasis by affecting E-cadherin and vimentin expression
- (2018) Kun Zhao et al. GENE
- S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties
- (2018) Jiao-Yang Li et al. CANCER LETTERS
- Targeting Eph/ephrin system in cancer therapy
- (2017) Alessio Lodola et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- EphA5 and EphA7 forward signaling enhances human hematopoietic stem and progenitor cell maintenance, migration, and adhesion via Rac1 activation
- (2017) Thao M. Nguyen et al. EXPERIMENTAL HEMATOLOGY
- Decreased expression of EphA5 is associated with Fuhrman nuclear grade and pathological tumour stage in ccRCC
- (2017) Xiaolin Wang et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Identification and characterization of Nanobodies targeting the EphA4 receptor
- (2017) Lies Schoonaert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
- (2017) Francesca Megiorni et al. Journal of Hematology & Oncology
- P2.06-001 A Study of MGCD516, a Receptor Tyrosine Kinase (RTK) Inhibitor, in Molecularly Selected Patients with NSCLC or Other Advanced Solid Tumors
- (2017) Theresa Werner et al. Journal of Thoracic Oncology
- Targeting receptor tyrosine kinase EphB4 in cancer therapy
- (2017) Yinnan Chen et al. SEMINARS IN CANCER BIOLOGY
- Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression
- (2017) Shibao Li et al. Cell Death & Disease
- Isoform expression patterns of EPHA10 protein mediate breast cancer progression by regulating the E-Cadherin and β-catenin complex
- (2017) Ye Li et al. Oncotarget
- Loss of the EPH receptor B6 contributes to colorectal cancer metastasis
- (2017) Silvia Mateo-Lozano et al. Scientific Reports
- High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer
- (2017) Ching-Yih Lin et al. Journal of Cancer
- A drug–drug interaction study of everolimus (an mTOR inhibitor) and JI-101, an orally active inhibitor of VEGF 2, PDGF, and EphB4 receptors, in patients with advanced urologic tumors.
- (2017) N. Agarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7
- (2017) Xiangkun Wu et al. PLoS One
- A role of the SAM domain in EphA2 receptor activation
- (2017) Xiaojun Shi et al. Scientific Reports
- EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation
- (2016) Yuho Hamaoka et al. CELLULAR SIGNALLING
- Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer
- (2016) Mariangela De Robertis et al. CLINICAL CANCER RESEARCH
- EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary Thyroid Cancer
- (2016) Jing-Jing Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway
- (2016) Yi Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study
- (2016) Ronan T. Swords et al. LEUKEMIA RESEARCH
- Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells
- (2016) RONGHUI LI et al. Molecular Medicine Reports
- Mechanisms of ephrin–Eph signalling in development, physiology and disease
- (2016) Artur Kania et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway
- (2016) Juan Peng et al. TUMOR BIOLOGY
- EphA4-mediated signaling regulates the aggressive phenotype of irradiation survivor colorectal cancer cells
- (2016) Priscila Guimarães de Marcondes et al. TUMOR BIOLOGY
- EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma
- (2016) Xiao Chen et al. Journal of Ovarian Research
- EphA8 is a prognostic marker for epithelial ovarian cancer
- (2016) Xiaoqin Liu et al. Oncotarget
- EphB6 overexpression and Apc mutation together promote colorectal cancer
- (2016) Dan Xu et al. Oncotarget
- EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer
- (2016) Anna-Maria Husa et al. Oncotarget
- The intrinsically kinase-inactive EPHB6 receptor predisposes cancer cells to DR5-induced apoptosis by promoting mitochondrial fragmentation
- (2016) Amr M. El Zawily et al. Oncotarget
- Low EphA7 Expression Correlated with Lymph Node Metastasis and Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma
- (2015) Yu-Qin Bai et al. ACTA HISTOCHEMICA ET CYTOCHEMICA
- Downregulation of EphA5 by promoter methylation in human prostate cancer
- (2015) Shibao Li et al. BMC CANCER
- The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of Integrin-β8 in prostate cancer cells
- (2015) Inga Mertens-Walker et al. BMC CANCER
- Effect of EphA7 Silencing on Proliferation, Invasion and Apoptosis in Human Laryngeal Cancer Cell Lines Hep-2 and AMC-HN-8
- (2015) Cheng Xiang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph–ephrin system
- (2015) Riccardo Castelli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A pilot study of JI-101, an inhibitor of VEGFR-2, PDGFR-β, and EphB4 receptors, in combination with everolimus and as a single agent in an ovarian cancer expansion cohort
- (2015) Theresa L. Werner et al. INVESTIGATIONAL NEW DRUGS
- Receptor Tyrosine Kinase EphA5 Is a Functional Molecular Target in Human Lung Cancer
- (2015) Fernanda I. Staquicini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System
- (2015) K. R. Kampen et al. MOLECULAR CANCER RESEARCH
- Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenicKRasin promoting lung adenocarcinoma
- (2015) Narayana Yeddula et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression
- (2015) Shibao Li et al. Oncotarget
- Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice
- (2015) Hironobu Takano et al. Oncotarget
- Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma
- (2015) Parag P. Patwardhan et al. Oncotarget
- Abstract 1753: GLPG1790: The first Ephrin (EPH) receptor tyrosine kinase inhibitor for the treatment of triple negative breast cancer
- (2015) Philippe Pujuguet et al. CANCER RESEARCH
- The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study
- (2015) Rishil J. Kathawala et al. Oncotarget
- Dimerization of the EphA1 Receptor Tyrosine Kinase Transmembrane Domain: Insights into the Mechanism of Receptor Activation
- (2014) Matthieu Chavent et al. BIOCHEMISTRY
- Ligand stimulation induces clathrin- and Rab5-dependent downregulation of the kinase-dead EphB6 receptor preceded by the disruption of EphB6-Hsp90 interaction
- (2014) Odette Allonby et al. CELLULAR SIGNALLING
- EphB6 promotes anoikis by modulating EphA2 signaling
- (2014) Mai Akada et al. CELLULAR SIGNALLING
- Investigation of the interactions between the EphB2 receptor and SNEW peptide variants
- (2014) Buyong Ma et al. GROWTH FACTORS
- Generation and characterization of a single-chain anti-EphA2 antibody
- (2014) Yehuda Goldgur et al. GROWTH FACTORS
- Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis
- (2014) Libo Peng et al. JOURNAL OF MOLECULAR HISTOLOGY
- Dynamic Interactions between Cancer Cells and the Embryonic Microenvironment Regulate Cell Invasion and Reveal EphB6 as a Metastasis Suppressor
- (2014) C. M. Bailey et al. MOLECULAR CANCER RESEARCH
- SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer
- (2014) Kerstin Rönsch et al. Molecular Oncology
- EphB4 regulates the growth and migration of pancreatic cancer cells
- (2014) Man Li et al. TUMOR BIOLOGY
- Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion
- (2014) CHENGLI LIU et al. Oncology Letters
- EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
- (2013) Bryan W. Day et al. CANCER CELL
- Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells
- (2013) Sahiti Chukkapalli et al. EXPERIMENTAL CELL RESEARCH
- EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition
- (2013) Qing Gao et al. HUMAN PATHOLOGY
- Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival
- (2013) L. Teng et al. NEURO-ONCOLOGY
- Design and Synthesis of Potent Bivalent Peptide Agonists Targeting the EphA2 Receptor
- (2013) Srinivas Duggineni et al. ACS Medicinal Chemistry Letters
- EphB4 promotes or suppresses Ras/MEK/ERK pathway in a context-dependent manner
- (2012) Zhan Xiao et al. CANCER BIOLOGY & THERAPY
- Abstract 1195: EphA4 is a novel tumor suppressor in lung adenocarcinoma
- (2012) Shaohua Peng CANCER RESEARCH
- Eph receptors and ephrins as targets for cancer therapy
- (2012) Hong-Qing Xi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Suppression of EphB4 improves the inhibitory effect of mTOR shRNA on the biological behaviors of ovarian cancer cells by down-regulating Akt phosphorylation
- (2012) Xiangyi Ma et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Effects of Cancer-Associated EPHA3 Mutations on Lung Cancer
- (2012) Guanglei Zhuang et al. JNCI-Journal of the National Cancer Institute
- Clinical implications of EphB4 receptor expression in pancreatic cancer
- (2012) Man Li et al. MOLECULAR BIOLOGY REPORTS
- Global Evaluation of Eph Receptors and Ephrins in Lung Adenocarcinomas Identifies EphA4 as an Inhibitor of Cell Migration and Invasion
- (2012) P. Saintigny et al. MOLECULAR CANCER THERAPEUTICS
- EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion
- (2012) Arend H. Sikkema et al. NEURO-ONCOLOGY
- EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase
- (2012) S D Wang et al. ONCOGENE
- A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo
- (2012) Aaron Petty et al. PLoS One
- Mutations of the EPHB6 Receptor Tyrosine Kinase Induce a Pro-Metastatic Phenotype in Non-Small Cell Lung Cancer
- (2012) Etmar Bulk et al. PLoS One
- Overexpression of the B-type Eph and ephrin genes correlates with progression and pain in human pancreatic cancer
- (2012) ZHENHUI LU et al. Oncology Letters
- EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex
- (2012) Guo Li et al. Nature Communications
- Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells
- (2011) Yong-qiang Hua et al. BIOMEDICINE & PHARMACOTHERAPY
- EphB3 Is Overexpressed in Non-Small-Cell Lung Cancer and Promotes Tumor Metastasis by Enhancing Cell Survival and Migration
- (2011) X.-D. Ji et al. CANCER RESEARCH
- A Disalicylic Acid-Furanyl Derivative Inhibits Ephrin Binding to a Subset of Eph Receptors
- (2011) Roberta Noberini et al. Chemical Biology & Drug Design
- Dasatinib: An Anti-Tumour Agent via Src Inhibition
- (2011) Antonio Gnoni et al. CURRENT DRUG TARGETS
- MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma
- (2011) Dong-Cai Liu et al. DIAGNOSTIC CYTOPATHOLOGY
- Crystal structure of the EphA4 protein tyrosine kinase domain in the apo- and dasatinib-bound state
- (2011) Carine Farenc et al. FEBS LETTERS
- Ectodomain structures of Eph receptors
- (2011) Juha P. Himanen SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis
- (2010) Georg Martiny-Baron et al. ANGIOGENESIS
- The EphB6 Receptor Cooperates with c-Cbl to Regulate the Behavior of Breast Cancer Cells
- (2010) L. Truitt et al. CANCER RESEARCH
- The EphB2 tumor suppressor induces autophagic cell death via concomitant activation of the ERK1/2 and PI3K pathways
- (2010) Mustapha Kandouz et al. CELL CYCLE
- The EPHB6 Receptor Tyrosine Kinase Is a Metastasis Suppressor That Is Frequently Silenced by Promoter DNA Hypermethylation in Non-Small Cell Lung Cancer
- (2010) J. Yu et al. CLINICAL CANCER RESEARCH
- EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma
- (2010) J. W. Lee et al. CLINICAL CANCER RESEARCH
- 400 Phase I study of JI-101, a novel oral tyrosine kinase inhibitor that selectively targets EphB4, VEGFR2, and PDGFRβ
- (2010) M. Gordon et al. EJC SUPPLEMENTS
- EphA2Mutation in Lung Squamous Cell Carcinoma Promotes Increased Cell Survival, Cell Invasion, Focal Adhesions, and Mammalian Target of Rapamycin Activation
- (2010) Leonardo Faoro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells
- (2010) Jonathan W. Astin et al. NATURE CELL BIOLOGY
- Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival
- (2009) N I Herath et al. BRITISH JOURNAL OF CANCER
- EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
- (2009) Hui Miao et al. CANCER CELL
- Cell adhesion and EGFR activation regulate EphA2 expression in cancer
- (2009) Alice Bjerregaard Larsen et al. CELLULAR SIGNALLING
- Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer
- (2009) De-Yuan Fu et al. HUMAN PATHOLOGY
- EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility
- (2009) T. Yamazaki et al. JOURNAL OF CELL SCIENCE
- EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells
- (2009) B P Fox et al. ONCOGENE
- Clinical Significance of Ephrin (Eph)-A1, -A2, -A4, -A5 and -A7 Receptors in Pancreatic Ductal Adenocarcinoma
- (2009) Constantinos Giaginis et al. PATHOLOGY & ONCOLOGY RESEARCH
- Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients
- (2008) Lin-Fang Wang et al. BMC CANCER
- Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
- (2008) Q Chang et al. BRITISH JOURNAL OF CANCER
- A Human Antibody-Drug Conjugate Targeting EphA2 Inhibits Tumor Growth In vivo
- (2008) D. Jackson et al. CANCER RESEARCH
- Aberrant methylation ofEphA7in human prostate cancer and its relation to clinicopathologic features
- (2008) Ming Guan et al. INTERNATIONAL JOURNAL OF CANCER
- Crystal Structure and NMR Binding Reveal That Two Small Molecule Antagonists Target the High Affinity Ephrin-binding Channel of the EphA4 Receptor
- (2008) Haina Qin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors
- (2008) Roberta Noberini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
- (2008) Alex J Eustace et al. Journal of Translational Medicine
- EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line
- (2008) J. Fukai et al. MOLECULAR CANCER THERAPEUTICS
- EphB1 Is Underexpressed in Poorly Differentiated Colorectal Cancers
- (2008) Zhen Sheng et al. PATHOBIOLOGY
- Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers
- (2008) Mariko Oki et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now